Pliant Therapeutics, Inc. (PLRX) Misses Q1 EPS by 15c
Tweet
Share
E-mailGet Alerts PLRX Hot Sheet
Join SI Premium – FREE
Pliant Therapeutics, Inc. (NASDAQ: PLRX) reported Q1 EPS of ($0.92), $0.15 worse than the analyst estimate of ($0.77).
For earnings history and earnings-related data on Pliant Therapeutics, Inc. (PLRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Morgan Stanley upgrades Robinhood, sees 43% upside
- Yext, Inc. (YEXT) Tops Q2 EPS by 4c
- Gap to Introduce New Line of Handbags From Former Coach Designer - WSJ
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
